Name: Communicating about Risks and Safe Use of Medicines: Real Life and Applied Research (en Inglés)
Price: 192380.00 CLP
Availability: InStock
Author: Bahri, Priya
ISBN: 9789811530128

portada Communicating about Risks and Safe Use of Medicines: Real Life and Applied Research (en Inglés)

Formato

Libro Físico

Editorial

Adis

Autor

Bahri, Priya

Idioma

Inglés

N° páginas

504

Encuadernación

Tapa Dura

Dimensiones

23.7 x 16.4 x 3.1 cm

Peso

1.04 kg.

ISBN13

9789811530128

N° edición

Categorías

Farmacología

Communicating about Risks and Safe Use of Medicines: Real Life and Applied Research (en Inglés)

Bahri, Priya (Autor) · Adis · Tapa Dura

Libro Nuevo

$ 192.380

$ 320.630

Ahorras: $ 128.250

40% descuento

Envío normal

Origen: Reino Unido (Costos de importación incluídos en el precio)

Se enviará desde nuestra bodega entre el Jueves 04 de Julio y el Viernes 12 de Julio.

Lo recibirás en cualquier lugar de Chile entre 1 y 3 días hábiles luego del envío.

Reseña del libro "Communicating about Risks and Safe Use of Medicines: Real Life and Applied Research (en Inglés)"

At the core of this book lies the question how to approach medicines, risks and communication as a researcher - or anybody planning and evaluating a communication intervention, or wanting to understand communication events in private and the media. With a view to tackle current shortcomings of communication systems and processes for improved implementation, patient satisfaction and health outcomes, a multilayered approach is presented. This combines multiple data types and methods to obtain a wider and deeper understanding of the major parties and their interactions, as well as the healthcare, social and political contexts of information flows, how they interfere and which impact they have. Illustrated with real life experiences of safety concerns with medicines, worldwide active experts discuss the methods and contributions their disciplines can offer. With considerations on terminologies, tabulated overviews on communication types and outcomes, a patient-centred vision and plain language for non-medical readers, the book creates a platform for multidisciplinary collaborations amongst researchers as well as practitioners from communications, healthcare, the social sciences and pharmacovigilance. Importantly, it advocates for an active role of patients and highlights the achievements and aspirations of patient organisations. Finally, the book suggests establishing an inclusive discipline of humanities and epidemiology of medicinal product risk communication to realise full research potential. The authors are driven by the curiosity for communication as the most human behaviour, and as good health is amongst the basic human needs, medicinal product risk communication is an exciting research field of high global relevance.